TRAX
First Tracks Biotherapeutics Inc
There isn't enough reported data to score TRAX yet.
TRAX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate TRAX's fundamentals.
TRAX PE Valuation
TRAX has no meaningful PE right now: it lost money over the past year.
TRAX Forward outlook
There aren't enough analyst estimates for TRAX to show an outlook.
TRAX Earnings Per Share
TRAX Quarterly Revenue
TRAX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$31.9M | +$6.7M |
| Q1 2026 | -$32.6M | +$12.5M |
TRAX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.1% | +744K shares |
| 1 year | +2.9% | +998K shares |
TRAX has 36M diluted shares, up 2.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
TRAX Net Leverage
TRAX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TRAX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.2 | Neutral |
| Stochastic | 79.9 | Neutral |
TRAX's weekly RSI is 67 (neutral) and its Stochastic is 80 (neutral).
TRAX PE vs Healthcare Sector
TRAX has no meaningful PE right now: it lost money over the past year.
TRAX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $40.0 | 22% above |
| 20 week MA | $39.1 | 25% above |
TRAX is in an uptrend: it's above all two of its weekly moving averages, and 25% above its 20-week average.
TRAX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $23.5 | $48.7 | +107% |
It's up 107% so far in 2026.